https://www.selleckchem.com/pr....oducts/bms-927711.ht
01). Higher levels of ZNF667-AS1 were positively associated with the WHO grade ( = 0.018) and KPS score ( = 0.008). ROC assays revealed that the high ZNF667-AS1 expression had an AUC value of 0.8541 (95% CI 0.8148 to 0.8934) for glioma. Survival data revealed that glioma patients in the high ZNF667-AS1 expression group had significantly shorter 5-year overall survival ( = 0.0026) and disease-free survival ( = 0.0005) time than those in the low ZNF667-AS1 expression group. Moreover, multivariate analyses confirmed that the ZNF667-AS1
Curtir
Comentario
Compartilhar
